DNAX OTC
DNA Brands, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: -0.0%
1Y: -0.0%
3Y: -90.5%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$250K
+14.1% ▲
Net Income
-$523K
+25.6% ▲
EPS (Diluted)
$-0.00
+80.0% ▲
EBITDA
-$250K
-64.5% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $249K | $459K | $0 | $0 | $0 |
| YoY Growth | +1278.2% | +84.5% | -100.0% | +0.0% | +0.0% |
| Cost of Revenue | $249K | $4K | $0 | $0 | $0 |
| Gross Profit | $250 | $456K | $0 | $0 | $0 |
| Gross Margin | 0.1% | 99.2% | — | — | — |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $489K | $760K | $338K | $291K | $250K |
| Operating Expenses | $1M | $760K | $338K | $291K | $250K |
| Operating Income | -$1M | -$304K | -$338K | -$291K | -$250K |
| Operating Margin | -499.6% | -66.2% | — | — | — |
| Interest Expense | $0 | $0 | $30K | $551K | $273K |
| Income Before Tax | -$1M | -$304K | -$375K | -$703K | -$523K |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$1M | -$304K | -$375K | -$703K | -$523K |
| Net Margin | -500.0% | -66.2% | — | — | — |
| EPS (Diluted) | $-0.24 | $-0.00 | $-0.00 | $-0.00 | $-0.00 |
| EBITDA | -$1M | -$300K | -$338K | $16K | -$250K |
| Shares Outstanding | 5M | 511M | 534M | 678M | 2.64B |